Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Wnt, Eda, and Shh pathways are crucial for different stages of sweat gland development in mice.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

PRP treatment helps hair growth in most cases, but more research needed.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The gene for slick hair in Senepol cattle is located on chromosome 20 and may involve the SRD5A2 gene.

Flutamide reduces hair growth better but has more side effects.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

GLI2 increases follistatin production in human skin cells.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Finasteride may cause male infertility, stopping it can help.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.